Kosenar,
Your analysis may be spot on about governance, remuneration and performance but what we require MOST OF ALL at this time is assured funding. Without it, the Newcastle IRC plant project won't be completed, tested and proven in the next quarter.
This will require additional funding. The price of the stock is falling.
Unlike Foulthrow I can't see how the issue price of any new shares will be above the market price. So unless MT can pull a rabbit out of the hat, it seems additional shares will need to be issued at 2 cents or below if current trends continue.
I don't think this is in anyone's interests. However, with no news and more sellers exiting, professional investors may get further shares at a song. Of course without them the whole project will come to a grinding halt.
I don't know whether to be sad or glad at the cheap shares being issued or just plain disappointed that the whole affair has become so tortuous and we will have to endure yet another capital raising at a bargain barrel price.
Come on Mr T. Where's that rabbit Foulthrow is talking about?
- Forums
- ASX - By Stock
- APG
- Ann: Appendix 5B - Query & Response
Ann: Appendix 5B - Query & Response , page-35
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add APG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online